Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.37 |
| ▸ | MAPT | P10636 | 5/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | TP53 | P04637 | 3/20 | 0.37 |
| ▸ | PKM | P14618 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 4/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 3/20 | 0.35 |
| ▸ | CTSD | P07339 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19299341 | 1.00 | RAB9A (0.37) | RAB9AMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL21677960 | 0.96 | TSHR (0.38) | RAB9AMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL21677757 | 0.96 | PDK2 (0.40) | RAB9AMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL24518748 | 0.95 | PDK2 (0.38) | RAB9AMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL20619855 | 0.95 | PDK2 (0.38) | RAB9AMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL19298527 | 0.95 | TSHR (0.36) | RAB9AMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL20622576 | 0.95 | RAB9A (0.38) | RAB9AMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL20618948 | 0.95 | RAB9A (0.38) | RAB9AMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL24648458 | 0.95 | PDK2 (0.40) | RAB9AMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL24647899 | 0.94 | PDK2 (0.42) | RAB9AMAPTSMN1; SMN2ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210288264-A1 | Heterocyclic Compound And Organic Light Emitting Element Comprising Same | LG CHEM, LTD. (KR) | 2021-09-16 | — | — | US | disclosed |
| EP-3595025-B1 | ORGANIC LIGHT EMITTING ELEMENT | LG CHEMICAL LTD (KR) | 2020-12-30 | — | — | EP | disclosed |
| US-20200365814-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2020-11-19 | — | — | US | disclosed |
| US-20200035930-A1 | ORGANIC LIGHT EMITTING ELEMENT | LG CHEM, LTD. (KR) | 2020-01-30 | — | — | US | disclosed |
| WO-2019004787-A1 | ORGANIC LIGHT EMITTING ELEMENT | 주식회사 엘지화학 | 2019-01-03 | — | — | WO | disclosed |
| WO-2019004782-A1 | ORGANIC LIGHT EMITTING ELEMENT | 주식회사 엘지화학 | 2019-01-03 | — | — | WO | disclosed |
| WO-2017146466-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | 주식회사 엘지화학 | 2017-08-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210288264-A1 | Heterocyclic Compound And Organic Light Emitting Element Comprising Same | CRY1, CRY2, PER2 | RAB9A 2789/4885MAPT 1141/4885SMN1; SMN2 3898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.